Back

Clarifying the treatment-pathway effects and generalizability of FAITAVI

European Heart Journal

18 May 2026
Organised by: Logo
Read full article
ESC Journals VALVULAR, MYOCARDIAL, PERICARDIAL, PULMONARY, CONGENITAL HEART DISEASE Valvular Heart Disease

Contributors

Kan Wang
Kan Wang

Author

Chen Jiang
Chen Jiang

Author

Zongtao Liu
Zongtao Liu

Author

You may be interested in
thumbnail
Congress Session
The right beat for every heart: personalised care with EHRA-PATHS
30 March 2025
thumbnail
Congress Presentation
Analytical approaches to open label extension (OLE) after cardiovascular outocmes trials: Observations from the FOURIER and FOURIER-OLE trials
1 September 2025
thumbnail
Congress Presentation
Generalizability of the EAST-AFNET 4 trial: assessing outcomes of early rhythm-control therapy in patients with atrial fibrillation
27 August 2021
thumbnail
Congress Presentation
Strategy-specific effects of low-voltage area-targeted ablation added to pulmonary vein isolation: a meta-analysis of randomized controlled trials
13 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources